ArticleFrontiers in molecular biosciences2023

Co-administration of temozolomide (TMZ) and the experimental therapeutic targeting miR-10b, profoundly affects the tumorigenic phenotype of human glioblastoma cells.

Ming Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.